scholarly article | Q13442814 |
P356 | DOI | 10.1084/JEM.156.5.1398 |
P953 | full work available at URL | https://europepmc.org/articles/PMC2186850 |
https://europepmc.org/articles/PMC2186850?pdf=render | ||
https://rupress.org/jem/article-pdf/156/5/1398/1663396/1398.pdf | ||
P932 | PMC publication ID | 2186850 |
P698 | PubMed publication ID | 6215457 |
P5875 | ResearchGate publication ID | 16981726 |
P2093 | author name string | O. Stutman | |
S. Macphail | |||
P2860 | cites work | Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 |
Tumor bearer T cells suppress BCG-potentiated antitumor responses II. Characteristics of the efferent phase suppressor | Q71605632 | ||
Qed-1--a target for unrestricted killing by T cells | Q72077877 | ||
Interleukin 2 deficiency is a common feature of autoimmune mice | Q72097477 | ||
Enumeration of IL 2-secreting helper T cells by limiting dilution analysis, and demonstration of unexpectedly high levels of IL 2 production per responding cell | Q72103722 | ||
Polymorphism of histocompatibility genes in the mouse | Q93711404 | ||
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum | Q35062164 | ||
Ionizing Radiation and the Immune Response | Q35536959 | ||
Secondary in vitro responses of T lymphocytes to non-H-2 alloantigens self-H-2-restricted responses induced in heterologous serum are not dependent on primary-stimulating non-H-2 alloantigens | Q36335299 | ||
The Ly phenotype of suppressor T cells arising in mice subjected to a graft-versus-host reaction | Q36335363 | ||
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex | Q36340264 | ||
Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions | Q36343022 | ||
Primary in vitro cytotoxic response of NZB spleen cells to Qa-1b-associated antigenic determinants | Q36343102 | ||
Ontogeny of culture-generated suppressor cells | Q36343121 | ||
Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines | Q36343465 | ||
Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement-treated lymphocytes | Q36343577 | ||
Primary in vitro cytotoxic T cell response to non-major histocompatibility complex alloantigens in normal mice | Q36346786 | ||
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen | Q36358156 | ||
In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice | Q36358603 | ||
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens | Q36358831 | ||
Modification of murine T-cell cytotoxicity by preimmunization with M locus and H-2 incompatibilities | Q36358996 | ||
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression | Q36359655 | ||
Generation of suppressor cells in mice immunized with M locus-incompatible lymphocytes | Q39149477 | ||
Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells | Q39252959 | ||
Mouse Cell-Mediated Lympholysis Assay in Serum-Free and Mouse Serum-Supplemented Media: Culture Conditions and Genetic Factors | Q39330256 | ||
Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response | Q39371914 | ||
Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: a caveat for the interpretation of experiments done under "syngeneic" conditions | Q39519706 | ||
In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity | Q39754482 | ||
T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells | Q39788638 | ||
Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse | Q39869822 | ||
Heterologous sera: a target for in vitro cell-mediated cytotoxicity | Q39990665 | ||
Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse | Q40685343 | ||
Characterization of suppressor lymphocytes generated in vitro | Q40692037 | ||
Contrasting effects of H-2 and Mls immunization on the polyclonal mitogenicity of murine lymphocytes | Q40726005 | ||
Xenoserum-induced cytolytic "T" cells: polyclonal specificity with an apparent "anti-self" component, and cooperative induction | Q40736067 | ||
Appearance of non-specific suppressor T cells during in vitro culture | Q40828842 | ||
In vitro generation of nonspecific suppressor cells and their characterization | Q41523633 | ||
Requlation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cells | Q41632774 | ||
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells | Q44226332 | ||
Non-H-2 T-lymphocyte-mediated cytotoxicity after primary in vivo sensitization. | Q53966447 | ||
Suppressor-target interaction in alloantigen induced responses: induction of a second cell in the suppressive pathway | Q54522244 | ||
Regulation of the cytotoxic T cell response to minor histocompatibility antigens. | Q54532035 | ||
Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier | Q59067963 | ||
Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin | Q67282967 | ||
Regulation of the immune response. XI-Cell-mediated feedback of an in vitro cell-mediated immune response | Q68230620 | ||
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media | Q68517564 | ||
Antigenic strength investigated by cell-mediated lympholysis in mice | Q68518147 | ||
Lyt phenotypes of alloreactive precursor and effector cytotoxic T lymphocytes | Q70537804 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
cell-mediated immunity | Q189146 | ||
Isoantigens | Q74560356 | ||
P304 | page(s) | 1398-1414 | |
P577 | publication date | 1982-11-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens | |
P478 | volume | 156 |
Q72725165 | Allospecific suppression without requirement for participation of Ly 2+ cells |
Q45972793 | Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. |
Q41547207 | Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells |
Q70012838 | H-2-linked genes determine the level of the primary in vitro anti-Mls response |
Q72815095 | Independent inhibition of IL 2 synthesis and cell proliferation by anti-Ia antibodies in mixed lymphocyte responses to Mls |
Q41393566 | Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma |
Q36351226 | Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells |
Q33805908 | Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases |
Q40117800 | The Murine Antitumor Immune Response and Its Therapeutic Manipulation |
Q41867746 | Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens |
Search more.